Imidazoline versus alpha2-adrenoceptors in the control of gastric motility in mice

European Journal of Pharmacology

Volumn 705, Issue 1-3, 2013, Pages 61-67

  Zádori, Zoltán S ^a   Fehér, Ágnes ^a   Al Khrasani, Mahmoud ^a   Lackó, Erzsébet ^a   Tóth, Viktória E ^a   Brancati, Serena B ^b   Hein, Lutz ^c   Mátyus, Péter ^a   Gyires, Klára ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF CATANIA   (Italy)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

2 BFI; Agmatine; Alpha2 adrenoceptor; Gastric motility; Harmane; Imidazoline receptor

Indexed keywords

2 (1 METHYL 2 ISOINDOLINYLMETHYL) 2 IMIDAZOLINE; 2 (2 IMIDAZOLIN 2 YL)QUINOLINE; 2 [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] 4,4 DIMETHYL 1,3(2H,4H) ISOQUINOLINEDIONE; AGMATINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2A ADRENERGIC RECEPTOR; ALPHA 2B ADRENERGIC RECEPTOR; ALPHA 2C ADRENERGIC RECEPTOR; CLONIDINE; HARMAN; IDAZOXAN; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; IMIDAZOLINE I2 RECEPTOR; MOXONIDINE; RILMENIDINE;

ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOMACH FUNDUS; STOMACH MOTILITY; STOMACH MUSCLE;

AGMATINE; ANIMALS; ELECTRIC STIMULATION; FEMALE; GASTRIC EMPTYING; HARMINE; IMIDAZOLES; IMIDAZOLINE RECEPTORS; ISOQUINOLINES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; OXAZOLES; PIPERAZINES; RECEPTORS, ADRENERGIC, ALPHA-2; STOMACH;

EID: 84875333942     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.02.043     Document Type: Article

References (60)

1. R. Alemany, G. Olmos, and J.A. Garcia-Sevilla Labelling of I2B-imidazoline receptors by [3H]2-(2-benzofuranyl)-2-imidazoline (2-BFI) in rat brain and liver: characterization, regulation and relation to monoamine oxidase enzymes Naunyn Schmiedebergs Arch. Pharmacol. 356 1997 39 47
2. 2A-adrenergic receptor knockout mice Mol. Pharmacol. 56 1999 154 161
3. V. Andresen, and M. Camilleri Irritable bowel syndrome: recent and novel therapeutic approaches Drugs 66 2006 1073 1088
4. F. Aricioglu, and H. Altunbas Harmane induces anxiolysis and antidepressant-like effects in rats Ann. N.Y. Acad. Sci. 1009 2003 196 201
5. F. Aricioglu, E. Ercil, and G. Dulger Agmatine inhibits naloxone-induced contractions in morphine-dependent Guinea pig ileum Ann. N.Y. Acad. Sci. 1009 2003 147 151
6. T. Asai, M.D. Vickers, and I. Power Clonidine inhibits gastric motility in the rat Eur. J. Anaesthesiol. 14 1997 316 319
7. P.N. Bhandare, P.V. Rataboli, and R.S. D'Souza Dual action of clonidine on ethanol-induced gastric lesions: is the imidazoline-preferring receptor involved? Eur. J. Pharmacol. 199 1991 243 245
8. C. Blandizzi Enteric alpha-2 adrenoceptors: pathophysiological implications in functional and inflammatory bowel disorders Neurochem. Int. 51 2007 282 288
9. C. Blandizzi, G. Natale, R. Colucci, D. Carignani, G. Lazzeri, and M. Del Tacca Characterization of alpha 2-adrenoceptor subtypes involved in the modulation of gastric acid secretion Eur. J. Pharmacol. 278 1995 179 182
10. P. Bousquet, J. Feldman, and J. Schwartz Central cardiovascular effects of alpha adrenergic drugs: differences between catecholamines and imidazolines J. Pharmacol. Exp. Ther. 230 1984 232 236
11. 2-sites Br. J. Pharmacol. 112 1994 1065 1070
12. 2-adrenoceptors or imidazoline receptors? Naunyn Schmiedebergs Arch. Pharmacol. 357 1998 682 691
13. E.J. Cooper, A.L. Hudson, C.A. Parker, and N.G. Morgan Effects of the beta-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans Eur. J. Pharmacol. 482 2003 189 196
14. C. Dardonville, and I. Rozas Imidazoline binding sites and their ligands: an overview of the different chemical structures Med. Res. Rev. 24 2004 639 661
15. H. De Vos, G. Bricca, J. De Keyser, J.P. De Backer, P. Bousquet, and G. Vauquelin Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system Neuroscience 59 1994 589 598
16. R.M. Eglen, A.L. Hudson, D.A. Kendall, D.J. Nutt, N.G. Morgan, V.G. Wilson, and M.P. Dillon Seeing through a glass darkly: casting light on imidazoline 'I' sites Trends Pharmacol. Sci. 19 1998 381 390
17. 1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling Ann. N.Y. Acad. Sci. 763 1995 22 42
18. C. Farsang, and J. Kapocsi Imidazoline receptors: from discovery to antihypertensive therapy (facts and doubts) Brain Res. Bull. 49 1999 317 331
19. D. Felsen, P. Ernsberger, M.P. Meeley, and D.J. Reis Clonidine displacing substance is biologically active on smooth muscle Eur. J. Pharmacol. 142 1987 453 455
20. V.L. Friedrich Jr., G.P. Martinelli, G.D. Prell, and G.R. Holstein Distribution and cellular localization of imidazoleacetic acid-ribotide, an endogenous ligand at imidazol(in)e and adrenergic receptors, in rat brain J. Chem. Neuroanat. 33 2007 53 64
21. 2-adrenoceptor subtypes involved in gastric emptying, gastric motility and gastric mucosal defence Eur. J. Pharmacol. 528 2005 150 157
22. R. Furlan, S. Ardizzone, L. Palazzolo, A. Rimoldi, F. Perego, F. Barbic, M. Bevilacqua, L. Vago, P.G. Bianchi, and A. Malliani Sympathetic overactivity in active ulcerative colitis: effects of clonidine Am. J. Physiol. Regul. Integr. Comp. Physiol. 290 2006 224 232
23. 1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats Br. J. Pharmacol. 114 1995 751 754
24. X. Guan, and Y. Hu Imidazoline derivatives: a patent review (2006 - present) Expert Opin. Ther. Pat. 22 2012 1353 1365
25. A. Halaris, and J. Plietz Agmatine: metabolic pathway and spectrum of activity in brain CNS Drugs 21 2007 885 900
26. G.A. Head, and D.N. Mayorov Imidazoline receptors, novel agents and therapeutic potential Cardiovasc. Hematol. Agents Med. Chem. 4 2006 17 32
27. N. Houi, Y. Kamisaki, and T. Itoh Effects of histamine H2 receptor antagonists on acid secretion stimulated by imidazoline derivatives in isolated parietal cells Eur. J. Pharmacol. 144 1987 67 76
28. 2-imidazoline binding sites Neurochem. Int. 30 1997 47 53
29. A.L. Hudson, R. Gough, R. Tyacke, L. Lione, M. Lalies, J. Lewis, S. Husbands, P. Knight, F. Murray, P. Hutson, and D.J. Nutt Novel selective compounds for the investigation of imidazoline receptors Ann. N.Y. Acad. Sci. 881 1999 81 91
30. A.L. Hudson, R. Price, R.J. Tyacke, M.D. Lalies, C.A. Parker, and D.J. Nutt Harmane, norharmane and tetrahydro beta-carboline have high affinity for rat imidazoline binding sites Br. J. Pharmacol. Supp. U6-U6 1999 126
31. S.M. Husbands, R.A. Glennon, S. Gorgerat, R. Gough, R. Tyacke, J. Crosby, D.J. Nutt, J.W. Lewis, and A.L. Hudson beta-carboline binding to imidazoline receptors Drug Alcohol Depend. 64 2001 203 208
32. W. Kaliszan, J. Petrusewicz, and R. Kaliszan Imidazoline receptors in relaxation of acetylcholine-constricted isolated rat jejunum Pharmacol. Rep. 58 2006 700 710
33. F. Lechin, D.B. van der, C.L. Insausti, F. Gomez, S. Villa, A.E. Lechin, L. Arocha, and O. Oramas Treatment of ulcerative colitis with clonidine J. Clin. Pharmacol. 25 1985 219 226
34. G. Li, S. Regunathan, C.J. Barrow, J. Eshraghi, R. Cooper, and D.J. Reis Agmatine: an endogenous clonidine-displacing substance in the brain Science 263 1994 966 969
35. 2 receptors: target for new analgesics? Eur. J. Pharmacol. 658 2011 49 56
36. 2-adrenergic receptor subtypes b and c Science 273 1996 803 805
37. R.E. Link, M.S. Stevens, M. Kulatunga, M. Scheinin, G.S. Barsh, and B.K. Kobilka Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog Mol. Pharmacol. 48 1995 48 55
38. L. Liu, and I.M. Coupar Involvement of alpha-2 adrenoceptors in the effects of moxonidine on intestinal motility and fluid transport J. Pharmacol. Exp. Ther. 283 1997 1367 1374
39. G.J. Molderings, M. Burian, J. Homann, M. Nilius, and M. Göthert Potential relevance of agmatine as a virulence factor of Helicobacter pylori Dig. Dis. Sci. 44 1999 2397 2404
40. G.J. Molderings, M. Burian, S. Menzel, K. Donecker, J. Homann, M. Nilius, and M. Göthert Imidazoline recognition sites and stomach function Ann. N.Y. Acad. Sci. 881 1999 332 343
41. 2 imidazoline and sigma binding sites in the rat and human stomach J. Pharmacol. Exp. Ther. 285 1998 170 177
42. G.J. Molderings, and B. Haenisch Agmatine (decarboxylated L-arginine): physiological role and therapeutic potential Pharmacol. Ther. 133 2012 351 365
43. N.G. Morgan, S.L. Chan, M. Mourtada, L.K. Monks, and C.A. Ramsden Imidazolines and pancreatic hormone secretion Ann. N.Y. Acad. Sci. 881 1999 217 228
44. S.A. Munk, R.K. Lai, J.E. Burke, P.N. Arasasingham, A.B. Kharlamb, C.A. Manlapaz, E.U. Padillo, M.K. Wijono, D.W. Hasson, L.A. Wheeler, and M.E. Garst Synthesis and pharmacologic evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2. 2.1]heptane: a potent imidazoline1 receptor specific agent J. Med. Chem. 39 1996 1193 1195
45. I.F. Musgrave, and E. Badoer Harmane produces hypotension following microinjection into the RVLM: possible role of I(1)-imidazoline receptors Br. J. Pharmacol. 129 2000 1057 1059
46. C.A. Parker, N.J. Anderson, E.S. Robinson, R. Price, R.J. Tyacke, S.M. Husbands, M.P. Dillon, R.M. Eglen, A.L. Hudson, D.J. Nutt, M.P. Crump, and J. Crosby Harmane and harmalan are bioactive components of classical clonidine-displacing substance Biochemistry 43 2004 16385 16392
47. M. Philipp, M.E. Brede, K. Hadamek, M. Gessler, M.J. Lohse, and L. Hein Placental alpha(2)-adrenoceptors control vascular development at the interface between mother and embryo Nat. Genet. 31 2002 311 315
48. J.E. Piletz, T.R. Ivanov, J.D. Sharp, P. Ernsberger, C.H. Chang, R.T. Pickard, G. Gold, B. Roth, H. Zhu, J.C. Jones, J. Baldwin, and D.J. Reis Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization DNA Cell Biol. 19 2000 319 329
49. W. Raasch, S. Regunathan, G. Li, and D.J. Reis Agmatine, the bacterial amine, is widely distributed in mammalian tissues Life Sci. 56 1995 2319 2330
50. E.S. Robinson, N.J. Anderson, J. Crosby, D.J. Nutt, and A.L. Hudson Endogenous beta-carbolines as clonidine-displacing substances Ann. N.Y. Acad. Sci. 1009 2003 157 166
51. N. Shujaa, M. Al Khrasani, Z.S. Zádori, M. Rossi, P. Mátyus, J. Németh, L. Hein, and K. Gyires alpha(2)-adrenoceptor agonist-induced inhibition of gastric motor activity is mediated by alpha(2A)-adrenoceptor subtype in the mouse Neurochem. Int. 58 2011 708 713
52. J. Strömbom, R. Jokela, V. Saano, and W. Rolfsen Binding of strychnocarpine and related beta-carbolines to brain receptors in vitro Eur. J. Pharmacol. 214 1992 165 168
53. B. Szabó Imidazoline antihypertensive drugs: a critical review on their mechanism of action Pharmacol. Ther. 93 2002 1 35
54. J. Tack Prokinetics and fundic relaxants in upper functional GI disorders Curr. Opin. Pharmacol. 8 2008 690 696
55. J. Tack, P. Caenepeel, M. Corsetti, and J. Janssens Role of tension receptors in dyspeptic patients with hypersensitivity to gastric distention Gastroenterology 127 2004 1058 1066
56. 2-adrenoceptor types serve as autoreceptors in postganglionic sympathetic neurons Naunyn Schmiedebergs Arch. Pharmacol. 368 2003 504 512
57. T. Utkan, G. Ulak, H.G. Yildiran, M. Yardimoglu, and M.N. Gacar Investigation on the mechanism involved in the effects of agmatine on ethanol-induced gastric mucosal injury in rats Life Sci. 66 2000 1705 1711
58. J.E. Wikberg, S. Uhlen, and V. Chhajlani Medetomidine stereoisomers delineate two closely related subtypes of idazoxan (imidazoline) I-receptors in the guinea pig Eur. J. Pharmacol. 193 1991 335 340
59. T. Wittmann, F. Kiss, F. Izbeki, A.I. Rosztoczy, T.T. Varkonyi, R. Roka, and J. Lonovics Improvement of gastric emptying in patients with diabetic gastroparesis by moxonidine Gastroenterology 124 Supp 2003 222 223
60. Z.S. Zádori, N. Shujaa, S.B. Brancati, L. Hein, and K. Gyires Both alpha2B- and alpha2C-adrenoceptor subtypes are involved in the mediation of centrally induced gastroprotection in mice Eur. J. Pharmacol. 669 2011 115 120